-
Mashup Score: 2Emergency department-administered, high-dose buprenorphine may enhance opioid use disorder treatment outcomes | National Institute on Drug Abuse - 3 year(s) ago
Study finds treatment is safe and well tolerated in people with opioid use disorder experiencing withdrawal symptoms
Source: National Institute on Drug AbuseCategories: Addiction Medicine, Latest HeadlinesTweet
-
Mashup Score: 4Adolescent marijuana, alcohol use held steady during COVID-19 pandemic | National Institute on Drug Abuse - 3 year(s) ago
Marijuana use and drinking did not significantly change during the COVID-19 pandemic, despite record decreases in the substances’ perceived availability, according to a survey of 12th graders in the United States.
Source: National Institute on Drug AbuseCategories: Addiction Medicine, Latest HeadlinesTweet-
Adolescent marijuana use and binge drinking did not significantly change during the #COVID19 pandemic, despite record decreases in the substances’ perceived availability, according to a survey of 12th graders in the US. https://t.co/UM1CRH8D23 #NIDAscience #NIDAnews
-
-
Mashup Score: 2Connect with NIDA | National Institute on Drug Abuse - 3 year(s) ago
Each digest or category has a different collection of articles you can subscribe to receive in your email or add to your RSS reader of choice. Each digest email is sent once a month.
Source: National Institute on Drug AbuseCategories: Addiction Medicine, Latest HeadlinesTweet-
NIDA’s drug research articles and digests can be delivered to your email or via RSS. Select the content you would like to receive and subscribe today! https://t.co/PEdYeg1WeQ #NIDAnews https://t.co/xzJpXsdZlY
-
-
Mashup Score: 7Medical records analysis links cannabis use disorder in pregnancy to infant health problems | National Institute on Drug Abuse - 3 year(s) ago
Study adds to a growing body of evidence that prenatal exposure to cannabis may be associated with poor birth outcomes
Source: National Institute on Drug AbuseCategories: Addiction Medicine, Latest HeadlinesTweet-
A NIDA-supported study of nearly 5 million live births recorded in California from 2001 to 2012 found that babies born to mothers diagnosed w/cannabis use disorder at delivery were more likely to experience negative health outcomes. https://t.co/Beihswwyc2 #NIDAscience #NIDAnews
-
-
Mashup Score: 4Meetings & Events | National Institute on Drug Abuse - 3 year(s) ago
Meeting/Event National Association of Drug Court Professionals (NADCP) Annual Training Conference Wednesday, May 12, 2021 to Saturday, May 15, 2021 | National Harbor, Maryland …
Source: National Institute on Drug AbuseCategories: Addiction Medicine, Latest HeadlinesTweet-
#Scientists/#researchers: Meetings and conferences (even when virtual) are a great way to exchange ideas and hear the latest in #addiction science, #neuroscience, and substance use. Learn what's coming up next:https://t.co/spzJj6stKW #NIDAnews https://t.co/ZjkHMlUIkW
-
-
Mashup Score: 4Long-lasting medications may improve treatment satisfaction in people with opioid use disorder | National Institute on Drug Abuse - 3 year(s) ago
NIH leaders emphasize the importance of patient voices in addiction medication development
Source: National Institute on Drug AbuseCategories: Addiction Medicine, Latest HeadlinesTweet-
.@NIDAnews leaders emphasize the importance of patient voices in addiction medication development in a commentary on a study showing that long-lasting medications may improve treatment satisfaction in people with opioid use disorder. https://t.co/G2kgM5kRU3 #NIDAnews https://t.co/NH61hb4mTG
-
-
Mashup Score: 1Connect with NIDA | National Institute on Drug Abuse - 3 year(s) ago
Each digest or category has a different collection of articles you can subscribe to receive in your email or add to your RSS reader of choice. Each digest email is sent once a month.
Source: National Institute on Drug AbuseCategories: Addiction Medicine, Latest HeadlinesTweet-
NIDA offers a variety of email digests featuring cutting-edge drug research and trends, funding announcements, and more. Subscribe today: https://t.co/ecLX9ZXkXC #NIDAnews https://t.co/o4a6oosBrM
-
-
Mashup Score: 6Connect with NIDA | National Institute on Drug Abuse - 3 year(s) ago
Each digest or category has a different collection of articles you can subscribe to receive in your email or add to your RSS reader of choice. Each digest email is sent once a month.
Source: National Institute on Drug AbuseCategories: Addiction Medicine, Latest HeadlinesTweet-
Don’t miss the latest addiction science news! Subscribe to NIDA's Research Digest today. https://t.co/AZjHxDzTd3 #NIDAnews https://t.co/qtl6rpINBL
-
-
Mashup Score: 2To end HIV epidemic, we must address health disparities | National Institute on Drug Abuse - 3 year(s) ago
Expert report cites unequal progress in Southern U.S. and among marginalized groups
Source: National Institute on Drug AbuseCategories: Addiction Medicine, Latest HeadlinesTweet-
Although powerful tools to prevent and treat HIV exist, people may not use them if they are facing personal challenges that pose a more immediate hardship—like #SubstanceUse and #MentalHealth disorders. Read more about #HIV with #NIDAnews: https://t.co/pvTNWH8aua https://t.co/KTTKgCV0G7
-
-
Mashup Score: 2Unraveling neuroHIV in the Presence of Substance Use Disorders | National Institute on Drug Abuse - 3 year(s) ago
These reviews address how each of these addictive substances and HIV individually or collectively affect the immune system and subsequent clinical and behavioral outcomes
Source: National Institute on Drug AbuseCategories: Addiction Medicine, Latest HeadlinesTweet-
The December issue of the Journal of Neuroimmune Pharmacology (JNIP) explored neuroHIV in the presence of substance use disorders, via NIDA AIDS Research Program. https://t.co/OP6oneWFQV #NIDAnews
-
A NIDA-funded #nihHEALinitiatve study found that high-dose buprenorphine therapy, provided under emergency department care, is safe and well tolerated in people with opioid use disorder experiencing opioid withdrawal symptoms. https://t.co/JY1IdJFoNp #NIDAscience #NIDAnews https://t.co/eCY3vB7mWn